Strategic AAV Expertise Virovek offers specialized BAC-to-AAV production with scalable titers and multiple serotypes, presenting a strong value proposition for partners needing high-tidelity viral vectors and customizable production capabilities.

Licensing Opportunities All proprietary AAV technologies are available for non-exclusive licensing, enabling potential collaborations or technology licensing deals with research institutions and biotech players seeking access to advanced AAV platforms.

Global Collaboration Established customer base across the Americas and Eurasia with active outreach to Africa and Oceania suggests growth potential through global partnerships, co-development, and capacity expansion collaborations.

Growth Through Services Current services include gene cloning, baculovirus production, and large-scale AAV production in development for 293 cells, offering multiple entry points for contract research organizations and biotech customers needing end-to-end vector services.

Leadership and Momentum Recent CEO appointment and ongoing service line expansions indicate strategic momentum and potential for sales narratives around leadership-driven growth and expanded production capabilities.